Paraneoplastic neurologic syndromes: Pathogenesis and physiopathology

Brain Pathology

Volumn 9, Issue 2, 1999, Pages 275-284

  Dalmau, Josep ^a   Gultekin, Humayun S ^a   Posner, Jerome B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ANTIBODY; ION CHANNEL; NEURONAL NUCLEAR ANTIBODY; PURKINJE CELL CYTOPLASMIC ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL ANTIBODY;

ANTIBODY PRODUCTION; CONFERENCE PAPER; CYTOKINE RELEASE; DIAGNOSTIC VALUE; DISEASE MARKER; EATON LAMBERT SYNDROME; ENCEPHALITIS; HORMONE RELEASE; IMMUNE RESPONSE; MOUSE; NEUROMUSCULAR JUNCTION DISORDER; NEUROPATHOLOGY; NONHUMAN; PARANEOPLASTIC SYNDROME; T LYMPHOCYTE ACTIVATION;

EID: 0032954642     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1999.tb00226.x     Document Type: Conference Paper

References (56)

1. Ahern GL, O'Connor M, Dalmau J, Coleman A, Posner JB, Schomer DL, Herzog AG, Kolb DA, Mesulam M (1994) Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Neurology 44: 1270-1274
2. Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L (1996) Broken dogma: penetration of autoantibodies into living cells. Immunol Today 17: 163-164
3. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB (1988) Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 38: 1391-1398
4. Benyahia B, Liblau R, Merle-Béral H, Tourani J-M, Dalmau J, Delattre J-Y (1998) Cell-mediated auto-immunity in paraneoplastic neurologic syndromes with anti-Hu antibodies. Ann Neurol, in press
5. Bourin M, Hascoet M, Deguiral P (1996) 5-HTP induced diarrhea as a carcinoid syndrome model in mice? Fundam Clin Pharmacol 10: 450-457
6. Brashear HR, Caccamo DV, Heck A, Keeney PM (1991) Localization of antibody in the central nervous system of a patient with paraneoplastic encephalomyeloneuritis. Neurology 41: 1583-1587
7. Carpentier AF, Rosenfeld MR, Delattre J-Y, Whalen RG, Posner JB, Dalmau J (1998) DNA vaccination with HuD inhibits tumor growth of a neuroblastoma in mice. Clin Cancer Res 4: 2819-2824
8. Dalmau J (1997) Paraneoplastic syndromes of the nervous system: General pathogeneic mechanisms and diagnostic approaches. In: Handbook of Clinical Neurology, Vinken PJ, Bruyn GW (eds.), Volume 69, Chapter 17, pp. 319-328, Elsevier: Amsterdam
9. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB (1990) Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - a quantitative western blot analysis. Ann Neurol 27: 544-552
10. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB (1991) Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 41: 1757-1764
11. Dalmau J, Graus F, Cheung N-KV, Rosenblum MK, Ho A, Cañete A, Delattre JY, Thompson SJ, Posner JB (1995) Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75: 99-109
12. Dalmau J, Graus F, Rosenblum MK, Posner JB (1992) Anti-Hu-associated paraneoplastic encephalomyelitis/ sensory neuronopathy. A clinical study of 71 patients. Medicine 71: 59-72
13. Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, Balmaceda C, Batchelor T, Gerstner E, Eichen J, Frennier J, Posner JB, Rosenfeld MR (1999) Mal, a novel neuronal and testis specific protein, is recognized by the serum of patients with paraneoplastic neurologic disorders. Brain 122: 27-39
14. Dalmau JO, Posner JB (1997) Paraneoplastic syndromes affecting the nervous system. Semin Oncol 24: 318-328
15. Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB (1997) Motor neuron syndromes in cancer patients. Ann Neurol 41: 722-730
16. Fukunaga H, Engel AG, Lang B, Newsom-Davis J, Vincent A (1983) Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci USA 80: 7636-7640
17. Furneaux HM, Reich L, Posner JB (1990) Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40: 1085-1091
18. Gilbert JA, Bates LA, Ames MM (1995) Elevated aromatic-L-amino acid decarboxylase in human carcinoid tumors. Biochem Pharmacol 50: 845-850
19. Giometto B, Marchiori GC, Nicolao P, Scaravilli T, Lion A, Bardin PG, Tavolato B (1997) Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol 23: 468-474
20. Golan TD (1997) The nuclear compartment of living cells is not an absolute immunologically sequestered site: evidence for spontaneous intranuclear entry of lupus autoantibodies to living cells. Leukemia 11: 6-9
21. Graus F, Dalmau J, Reñé R, Torà M, Malats N, Verschuuren JJ, Cardenal F, Viñolas N, García del Muro J, Vadell C, Mason WP, Rosell R, Posner JB, Real FX (1997) Anti-Hu antibodies in patients with small cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 15: 2866-2872
22. Graus F, Dalmau J, Valldeoriola F, Ferrer I, Reñé R, Marin C, Vecht ChJ, Arbizu T, Targa C, Moll JWB (1997) Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 74: 55-61
23. Graus F, Ribalta T, Campo E, Monforte R, Urbano A, Rozman C (1990) Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 40: 219-222
24. Graus F, Segurado OG, Tolosa E (1988) Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration. Acta Neurol Scand 78: 210-213
25. Greenlee JE, Parks TN, Jaeckle KA (1993) Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro. Neurology 43: 2049-2054
26. Gultekin SH, Dalmau J, Graus Y, Posner JB, Rosenblum MK (1998) Anti-Hu immunolabeling as an index of neuronal differentiation in human brain tumors: a study of 112 central neuroepithelial neoplasms. Am J Surg Pathol 22: 195-200
27. Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, Morris C, Newsom-Davis J (1997) Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 41: 238-246
28. Hormigo A, Dalmau J, Rosenblum M, River ME, Posner JB (1994) Immunological and pathological study of anti-Ri associated encephalopathy. Ann Neurol 36: 896-902
29. Hormigo A, Lieberman F (1994) Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity. J Neuroimmunol 55: 205-212
30. Jean WC, Dalmau J, Ho A, Posner JB (1994) Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 44: 140-147
31. Lang B, Newsom-Davis J, Wray D (1981) Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1: 224-226
32. Lindstrom J, Shelton D, Fujii Y (1988) Myasthenia gravis. Adv Immunol 42: 233-284
33. Mason WP, Graus F, Lang B, Honnorat J, Delattre J-Y, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J (1997) Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120: 1279-1300
34. Miralles GD, O'Fallon JR, Talley NJ (1992) Plasma-cell dyscrasia with polyneuropathy. N Engl J Med 327: 1919-1923
35. Motomura M, Johnston I, Lang B, Vincent A, NewsomDavis J (1995) An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiat 58: 85-87
36. Nagel A, Engel AG, Lang B, Newsom-Davis J, Fukuoka T (1988) Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation. Ann Neurol 24: 552-558
37. Neumann H, Cavalie A, Jenne DE, Wekerle H (1995) Induction of MHC class I genes in neurons. Science 269: 549-552
38. Newsom-Davis J, Mills KR (1993) Immunological associations of acquired neuromyotonia (Isaac's syndrome). Report of five cases and literature review. Brain 116: 453-469
39. Newsom-Davis J, Murray NM (1984) Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome. Neurology 34: 480-485
40. O'Neill JH, Murray NM, Newsom-Davis J (1988) The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111: 577-596
41. Peterson K, Rosenblum MK, Kotanides H, Posner JB (1992) Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody positive patients. Neurology 42: 1931-1937
42. Posner JB (1995) Neurologic Complications of Cancer. F.A. Davis Company: Philadelphia
43. Rowland LP, Sherman WH, Latov N, Lange DJ, McDonald TD, Younger DS, Murphy PL, Hays AP, Knowles D (1992) Amyotrophic lateral sclerosis and lymphoma: bone marrow examination and other diagnostic tests. Neurology 42: 1101-1102
44. Schold SC, Cho ES, Somasundaram M, Posner JB (1979) Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol 5: 271-287
45. Sillevis Smitt PA, Manley GT, Posner JB (1995) Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology 45: 1873-1878
46. Sillevis-Smitt P, Manley G, Moll JWB, Dalmau J, Posner JB (1996) Pitfalls in the diagnosis of autoantibodies associated with paraneoplstic neurologic disease. Neurology 46: 1739-1741
47. Sindic CJ, Andersson M, Boucquey D, Chalon MP, Bisteau M, Brucher JM, Laterre EC (1993) Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration. Acta Neurologica Belgica 93: 65-77
48. Strassmann G, Jacob CO, Fong M, Bertolini DR (1993) Mechanisms of paraneoplastic syndromes of colon-26: involvement of interleukin 6 in hypercalcemia. Cytokine 5: 463-468
49. Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S (1995) Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin Neurol Neurosurg 97: 101-105
50. Tanaka M, Tanaka K, Onodera O, Tsuji S (1995) Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss. Clin Neurol Neurosurg 97: 95-100
51. Tora M, Graus F, de Bolos C, Real FX (1997) Cell surface expression of paraneoplastic encephalomyelitis/sensory neuronopathy-associated Hu antigens in small-cell lung cancers and neuroblastomas. Neurology 48: 735-741
52. Verschuuren J, Chuang L, Rosenblum MK, Lieberman F, Pryor A, Posner JB, Dalmau J (1996) Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol (Berl) 91: 519-525
53. Voltz R, Dalmau J, Posner JB, Rosenfeld MR (1998) T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology 51:1146-1150.
54. Voltz R, Gultekin H, Posner JB, Rosenfeld MR, Dalmau J (1998) Sera of patients with testicular cancer and paraneoplastic limbic/brainstem encephalitis harbor an antineuronal antibody (anti-Ta) that recognizes a novel neuronal protein. J Neurol 245: 379
55. Wilkinson PC, Zeromski J (1965) Immunofluorescent detection of antibodies against neurons in sensory carcinomatous neuropathy. Brain 88: 529-538
56. Younger DS, Rowland LP, Latov N, Hays AP, Lange DJ, Sherman W, Inghirami G, Pesce MA, Knowles DM, Powers J (1991) Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol 29: 78-86